Abraham Klepfish

734 total citations
21 papers, 486 citations indexed

About

Abraham Klepfish is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Abraham Klepfish has authored 21 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 9 papers in Immunology. Recurrent topics in Abraham Klepfish's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Abraham Klepfish is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Abraham Klepfish collaborates with scholars based in Israel, United States and France. Abraham Klepfish's co-authors include Simon Karpatkin, Mary Lynn Nierodzik, Ami Schattner, Lev Shvidel, Mordechai Shtalrid, Alain Berrébi, A. Berrebi, Ronit Sarid, Gilles Lugassy and Hussam Ghoti and has published in prestigious journals such as The Lancet, Blood and The Lancet Oncology.

In The Last Decade

Abraham Klepfish

21 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abraham Klepfish Israel 12 175 158 151 139 129 21 486
S Songcharoen United States 6 98 0.6× 123 0.8× 104 0.7× 141 1.0× 184 1.4× 7 654
Aldo Della Volpe Italy 9 124 0.7× 80 0.5× 128 0.8× 137 1.0× 180 1.4× 15 519
László Váróczy Hungary 13 223 1.3× 127 0.8× 85 0.6× 89 0.6× 64 0.5× 47 425
Emma Vernon United States 5 74 0.4× 105 0.7× 103 0.7× 176 1.3× 256 2.0× 9 738
Guido Gini Italy 12 241 1.4× 93 0.6× 210 1.4× 104 0.7× 184 1.4× 37 629
K. D. Watson United Kingdom 3 115 0.7× 126 0.8× 58 0.4× 244 1.8× 160 1.2× 3 724
Naonobu Sugiyama Japan 14 133 0.8× 133 0.8× 111 0.7× 359 2.6× 195 1.5× 34 871
Abraham Avigdor Israel 10 168 1.0× 76 0.5× 133 0.9× 69 0.5× 111 0.9× 14 426
Gavivann Veerakul Thailand 14 94 0.5× 163 1.0× 132 0.9× 61 0.4× 238 1.8× 34 744
Ni‐Chun Tsai United States 16 321 1.8× 103 0.7× 382 2.5× 130 0.9× 242 1.9× 48 712

Countries citing papers authored by Abraham Klepfish

Since Specialization
Citations

This map shows the geographic impact of Abraham Klepfish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Klepfish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Klepfish more than expected).

Fields of papers citing papers by Abraham Klepfish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Klepfish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Klepfish. The network helps show where Abraham Klepfish may publish in the future.

Co-authorship network of co-authors of Abraham Klepfish

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Klepfish. A scholar is included among the top collaborators of Abraham Klepfish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Klepfish. Abraham Klepfish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schattner, Ami & Abraham Klepfish. (2020). Orthodox Judaism as a Risk Factor of Covid-19 in Israel. The American Journal of the Medical Sciences. 360(3). 304–304. 17 indexed citations
2.
Schattner, Ami, et al.. (2015). Acute Splenic Infarction at an Academic General Hospital Over 10 Years. Medicine. 94(36). e1363–e1363. 48 indexed citations
3.
Klepfish, Abraham, Hananya Vaknine, & Ami Schattner. (2014). Never say never: unexpected herpes lymphadenitis. The Lancet. 384(9954). 1640–1640. 3 indexed citations
4.
Shvidel, Lev, Tamar Tadmor, Andrei Braester, et al.. (2014). Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group. European Journal Of Haematology. 93(1). 29–33. 22 indexed citations
5.
6.
Schattner, Ami & Abraham Klepfish. (2012). Left Pleural Effusion and Fever of Unknown Origin—A Clue to Thoracic Arterial Pathology. Journal of General Internal Medicine. 27(8). 1084–1087. 6 indexed citations
7.
Shvidel, Lev, Andrei Braester, Osnat Bairey, et al.. (2012). Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients. Annals of Hematology. 91(10). 1597–1602. 5 indexed citations
8.
Shvidel, Lev, Andrei Braester, Osnat Bairey, et al.. (2011). Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel. American Journal of Hematology. 86(12). 985–992. 10 indexed citations
9.
Klepfish, Abraham, et al.. (2009). Enhancing the Action of Rituximab in Chronic Lymphocytic Leukemia by Adding Fresh Frozen Plasma. Annals of the New York Academy of Sciences. 1173(1). 865–873. 45 indexed citations
10.
Klepfish, Abraham, Amichai Schattner, Hussam Ghoti, & Eliezer A. Rachmilewitz. (2007). Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemia. The Lancet Oncology. 8(4). 361–362. 28 indexed citations
11.
Shtalrid, M, et al.. (2004). Expression of Interleukin-11 Receptor in CD38-positive Cells from Patients with Multiple Myeloma. Leukemia & lymphoma. 45(11). 2315–2319. 2 indexed citations
12.
Leibovitz, Eyal, et al.. (2004). Persistent anemia in otherwise asymptomatic severe aortic stenosis: a possible indication for valve replacement?. PubMed. 6(7). 400–2. 10 indexed citations
13.
Conconi, Annarita, Michele Spina, Valeria Ascoli, et al.. (2004). An IELSG International Survey of Primary Effusion Lymphoma (PEL).. Blood. 104(11). 3265–3265. 2 indexed citations
14.
Shvidel, Lev, Mordechai Shtalrid, Abraham Klepfish, et al.. (2002). Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders. The Hematology Journal. 3(1). 32–37. 30 indexed citations
15.
Klepfish, Abraham, Ronit Sarid, Mordechai Shtalrid, et al.. (2001). Primary Effusion Lymphoma (PEL) in HIV-Negative Patients - a Distinct Clinical Entity. Leukemia & lymphoma. 41(3-4). 439–443. 67 indexed citations
16.
Shvidel, Lev, et al.. (2001). Over-Expression of the Functional Interleukin-11α Receptor in the Development of B-Cell Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 42(1-2). 195–205. 3 indexed citations
17.
18.
Shimoni, Avichai, et al.. (1998). Prolymphocytic transformation of B‐chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion. American Journal of Hematology. 59(4). 316–318. 1 indexed citations
19.
Nierodzik, Mary Lynn, Abraham Klepfish, & Simon Karpatkin. (1995). Role of Platelets, Thrombin, Integrin llb-llla, Fibronectin and Von Willebrand Factor on Tumor Adhesion in Vitro and Metastasis in Vivo. Thrombosis and Haemostasis. 74(1). 282–290. 125 indexed citations
20.
Berrébi, Alain, et al.. (1988). Gray platelet syndrome in the elderly. American Journal of Hematology. 28(4). 270–272. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Songcharoen Breakdown of academic impact, for papers by Aldo Della Volpe Breakdown of academic impact, for papers by László Váróczy Breakdown of academic impact, for papers by Emma Vernon Breakdown of academic impact, for papers by Guido Gini Breakdown of academic impact, for papers by K. D. Watson Breakdown of academic impact, for papers by Naonobu Sugiyama Breakdown of academic impact, for papers by Abraham Avigdor Breakdown of academic impact, for papers by Gavivann Veerakul Breakdown of academic impact, for papers by Ni‐Chun Tsai
Rankless by CCL
2026